Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib as Adjuvant Therapy for Lung and Esophageal Cancers, Thymic Neoplasms, Thoracic Sarcomas, and Malignant Pleural Mesotheliomas
Sponsor: National Cancer Institute (NCI)
Terminated
Closed accrual due to unpromising results and the opening of study 14C0053 targeting the same population.
Other terminated trials from National Cancer Institute (NCI)
Other Esophageal Cancer trials with similar outcome
Listed as NCT01143545, this PHASE1 trial focuses on Esophageal Cancer and Lung Cancer and remains terminated or withdrawn. Sponsored by National Cancer Institute (NCI), it has been updated 25 times since 2010, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
25 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE1
▶ Show 20 earlier versions
-
Apr 2020 — Nov 2020 [monthly]
Terminated PHASE1
Status: Completed → Terminated
-
Feb 2020 — Apr 2020 [monthly]
Completed PHASE1
-
Jan 2020 — Feb 2020 [monthly]
Completed PHASE1
-
Dec 2019 — Jan 2020 [monthly]
Completed PHASE1
-
Oct 2019 — Dec 2019 [monthly]
Completed PHASE1
-
Jul 2019 — Oct 2019 [monthly]
Completed PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Completed PHASE1
-
May 2019 — Jun 2019 [monthly]
Completed PHASE1
-
Apr 2019 — May 2019 [monthly]
Completed PHASE1
-
Mar 2019 — Apr 2019 [monthly]
Completed PHASE1
-
Feb 2019 — Mar 2019 [monthly]
Completed PHASE1
-
Jan 2019 — Feb 2019 [monthly]
Completed PHASE1
-
Dec 2018 — Jan 2019 [monthly]
Completed PHASE1
-
Nov 2018 — Dec 2018 [monthly]
Completed PHASE1
-
Oct 2018 — Nov 2018 [monthly]
Completed PHASE1
-
Sep 2018 — Oct 2018 [monthly]
Completed PHASE1
-
Aug 2018 — Sep 2018 [monthly]
Completed PHASE1
-
Jun 2018 — Aug 2018 [monthly]
Completed PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1
First recorded
Dec 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .